Neobe Therapeutics
Neobe Therapeutics is a startup headquartered in Cambridge, United Kingdom, founded in 2021. It has won about £1.00m in competitive Innovate UK grants since 2023, according to UK Research and Innovation.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Innovation grants
Neobe Therapeutics has won about £1.00m in competitive Innovate UK grants since 2023.
- Development and validation of a tumour inducible promoter platform for engineered live biotherapeutics (£305k, 2024)
- Pre-clinical development of a live biotherapeutic product engineered to remodel hyaluronic acid in solid tumours to enable checkpoint inhibitor efficacy (£700k, 2023)
R&D ecosystem
Neobe Therapeutics sits inside the London and the Golden Triangle R&D ecosystem in the Global R&D Labs Directory.
Other startups in Cambridge
- Coherence Neuro
- Deepform
- Ethicronics
- Inkle
- Kubos Semiconductors
- Momentous Therapeutics
- Panakeia Technologies
- Rapidx Bio
- Reactwise Technologies
- Spotta
- The Vaccine Group
Related
- Innovation profile of Cambridge
- United Kingdom: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Neobe Therapeutics do?
Neobe Therapeutics works in biotechnology. Its Innovate UK projects include: Development and validation of a tumour inducible promoter platform for engineered live biotherapeutics.
Where is Neobe Therapeutics based?
Neobe Therapeutics is headquartered in Cambridge, United Kingdom.
When was Neobe Therapeutics founded?
Neobe Therapeutics was founded in 2021.
Source records: Companies House and UK Research and Innovation.
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.